BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34257160)

  • 1. Implication of integrin α2β1 in senescence of SK-Mel-147 human melanoma cells.
    Kozlova NI; Morozevich GE; Berman AE
    Aging (Albany NY); 2021 Jul; 13(14):18006-18017. PubMed ID: 34257160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implication of integrins α3β1 and α5β1 in invasion and anoikis of SK-Mel-147 human melanoma cells: non-canonical functions of protein kinase Akt.
    Kozlova NI; Morozevich GE; Gevorkian NM; Berman AE
    Aging (Albany NY); 2020 Dec; 12(23):24345-24356. PubMed ID: 33260159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Integrin α3β1 signaling in regulation of the SK-Mel-147 melanoma cell senescence].
    Morozevic GE; Kozlova NI; Gevorkian NM; Berman AE
    Biomed Khim; 2022 Jan; 68(1):39-46. PubMed ID: 35221295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implication of Integrin α2β1 in Proliferation and Invasion of Human Breast Carcinoma and Melanoma Cells: Noncanonical Function of Akt Protein Kinase.
    Kozlova NI; Morozevich GE; Ushakova NA; Berman AE
    Biochemistry (Mosc); 2018 Jun; 83(6):738-745. PubMed ID: 30195330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of integrin α5β1 in senescence of SK-Mel-147 human melanoma cells.
    Kozlova NI; Morozevich GE; Gevorkian NM; Kurbatov LK; Berman AE
    Biomed Khim; 2023 Jun; 69(3):156-164. PubMed ID: 37384907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of integrin α2β1 in anoikis of SK-Mel-147 human melanoma cells: a non-canonical function of Akt protein kinase.
    Kozlova NI; Morozevich GE; Ushakova NA; Berman AE
    Oncotarget; 2019 Mar; 10(19):1829-1839. PubMed ID: 30956761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal Adhesion- and IGF1R-Dependent Survival and Migratory Pathways Mediate Tumor Resistance to mTORC1/2 Inhibition.
    Yoon SO; Shin S; Karreth FA; Buel GR; Jedrychowski MP; Plas DR; Dedhar S; Gygi SP; Roux PP; Dephoure N; Blenis J
    Mol Cell; 2017 Aug; 67(3):512-527.e4. PubMed ID: 28757207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCM7 silencing promotes cutaneous melanoma cell autophagy and apoptosis by inactivating the AKT1/mTOR signaling pathway.
    Yang Y; Ma S; Ye Z; Zhou X
    J Cell Biochem; 2020 Feb; 121(2):1283-1294. PubMed ID: 31535400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-tumor NC1 domain of collagen XIX inhibits the FAK/ PI3K/Akt/mTOR signaling pathway through αvβ3 integrin interaction.
    Oudart JB; Doué M; Vautrin A; Brassart B; Sellier C; Dupont-Deshorgue A; Monboisse JC; Maquart FX; Brassart-Pasco S; Ramont L
    Oncotarget; 2016 Jan; 7(2):1516-28. PubMed ID: 26621838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Flavonol Isoquercitrin Promotes Mitochondrial-Dependent Apoptosis in SK-Mel-2 Melanoma Cell via the PI3K/AKT/mTOR Pathway.
    Won YS; Kim JH; Lizardo RCM; Min HJ; Cho HD; Hong SM; Seo KI
    Nutrients; 2020 Nov; 12(12):. PubMed ID: 33260329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAFV600E cooperates with PI3K signaling, independent of AKT, to regulate melanoma cell proliferation.
    Silva JM; Bulman C; McMahon M
    Mol Cancer Res; 2014 Mar; 12(3):447-63. PubMed ID: 24425783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PI3K/AKT/mTOR pathway inhibitors inhibit the growth of melanoma cells with mTOR H2189Y mutations in vitro.
    Wu X; Yu J; Yan J; Dai J; Si L; Chi Z; Sheng X; Cui C; Ma M; Tang H; Xu T; Yu H; Kong Y; Guo J
    Cancer Biol Ther; 2018 Jul; 19(7):584-589. PubMed ID: 29708815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitions of mTORC1 and 4EBP-1 are key events orchestrated by Rottlerin in SK-Mel-28 cell killing.
    Daveri E; Maellaro E; Valacchi G; Ietta F; Muscettola M; Maioli E
    Cancer Lett; 2016 Sep; 380(1):106-13. PubMed ID: 27343979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoegomaketone induces apoptosis in SK-MEL-2 human melanoma cells through mitochondrial apoptotic pathway via activating the PI3K/Akt pathway.
    Kwon SJ; Lee JH; Moon KD; Jeong IY; Yee ST; Lee MK; Seo KI
    Int J Oncol; 2014 Nov; 45(5):1969-76. PubMed ID: 25119993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SKLB-M8 induces apoptosis through the AKT/mTOR signaling pathway in melanoma models and inhibits angiogenesis with decrease of ERK1/2 phosphorylation.
    Wang J; Yang Z; Wen J; Ma F; Wang F; Yu K; Tang M; Wu W; Dong Y; Cheng X; Nie C; Chen L
    J Pharmacol Sci; 2014; 126(3):198-207. PubMed ID: 25341684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous hydrogen sulfide inhibits human melanoma cell development via suppression of the PI3K/AKT/ mTOR pathway.
    Xiao Q; Ying J; Qiao Z; Yang Y; Dai X; Xu Z; Zhang C; Xiang L
    J Dermatol Sci; 2020 Apr; 98(1):26-34. PubMed ID: 32098704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway.
    Sun X; Shi B; Zheng H; Min L; Yang J; Li X; Liao X; Huang W; Zhang M; Xu S; Zhu Z; Cui H; Liu X
    Cell Death Dis; 2018 Feb; 9(3):260. PubMed ID: 29449532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors.
    Smit DJ; Cayrefourcq L; Haider MT; Hinz N; Pantel K; Alix-Panabières C; Jücker M
    Cells; 2020 Sep; 9(9):. PubMed ID: 32962206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual inhibition of Akt and ERK signaling induces cell senescence in triple-negative breast cancer.
    He Q; Xue S; Tan Y; Zhang L; Shao Q; Xing L; Li Y; Xiang T; Luo X; Ren G
    Cancer Lett; 2019 Apr; 448():94-104. PubMed ID: 30742942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells.
    Bonelli MA; Digiacomo G; Fumarola C; Alfieri R; Quaini F; Falco A; Madeddu D; La Monica S; Cretella D; Ravelli A; Ulivi P; Tebaldi M; Calistri D; Delmonte A; Ampollini L; Carbognani P; Tiseo M; Cavazzoni A; Petronini PG
    Neoplasia; 2017 Aug; 19(8):637-648. PubMed ID: 28704762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.